Oral NMN Supplementation & UV-B Photoaging: What the 2025 Science Reveals

By: Dr. Katerina Noel

Your Sunscreen Can't Fix What's Happening Inside Your Cells

By your 40s, your skin's NAD+ levels have dropped by up to 50% compared to youth, with decline beginning as early as your late 20s. That statistic reframes everything we know about sun protection. Conventional SPF shields the skin's surface from UV radiation, but it cannot repair the intracellular damage driven by NAD+ depletion.

NMN (β-Nicotinamide Mononucleotide) is a direct precursor to NAD+, and it is not the same molecule as niacinamide, the vitamin B3 derivative commonly found in serums. The distinction matters because their biological pathways and clinical outcomes are fundamentally different.

In November 2025, a peer-reviewed study by Kim et al. (Antioxidants, DOI: 10.3390/antiox14121424) became the first to comprehensively demonstrate oral NMN's multifaceted protection against UV-B photoaging. Below, we break down the molecular science, the clinical evidence, and what this means for a proactive longevity skincare protocol.

Why NAD+ Decline Makes Aging Skin Uniquely Vulnerable to UV-B Damage

NAD+ is the master coenzyme powering cellular energy production, DNA repair, and sirtuin activation. Without adequate NAD+, cells cannot maintain the repair processes that keep tissue healthy. Skin is one of the most severely affected tissues: according to NutritionFacts.org, NAD+ levels in skin drop more than 50% from newborns to young adults, then a further 60% from young adults to middle age.

Consider the threat. UV-B radiation (280–320 nm) represents only 1–2% of total solar UV, yet it is the primary environmental carcinogen linked to approximately 65% of melanoma cases and 90% of non-melanoma skin cancers. When NAD+ is depleted, the skin's intrinsic repair machinery is impaired at precisely the moment UV-B exposure inflicts the most damage. The result is a compounding vulnerability: diminished repair capacity meeting greater oxidative stress.

For women, this timeline carries additional weight. NAD+ decline accelerates around age 36–40 and may intensify during perimenopause, creating a critical window where hormonal shifts and cellular energy deficits converge. Collagen production also declines by roughly 1% per year with age, further compounding UV-B-induced matrix degradation. The biology is clear: aging skin is not merely more vulnerable to photoaging in appearance. It is more vulnerable at the molecular level.

The 2025 Breakthrough: What the Kim et al. Study Actually Found

The Kim et al. study, conducted at Gachon University in collaboration with LG Household & Healthcare and published in Antioxidants (November 2025), is the first to demonstrate oral NMN's multifaceted anti-photoaging benefits within a single model. That comprehensiveness is what makes it significant.

Using a 10-week SKH-1 hairless mouse model, researchers administered oral NMN alongside chronic UV-B exposure. The NMN-supplemented group showed significantly reduced epidermal hypertrophy, fewer wrinkles, and markedly less skin surface roughness compared to UV-B-exposed controls.

Skin barrier outcomes were equally striking. Hydration and elasticity improved measurably, and transepidermal water loss (TEWL) was restored to near-normal levels. TEWL is a clinically meaningful metric: it quantifies how much moisture escapes through the skin barrier, and elevated TEWL is a hallmark of compromised, photoaged skin.

Histological analyses revealed marked preservation of collagen fiber density and attenuation of dermal matrix degradation in the NMN group. Critically, these outcomes were driven by oral supplementation, not topical application. Systemic NMN intake produced measurable, structural changes at the skin level, validating an inside-out model of photoprotection.

The Molecular Mechanisms: How NMN Protects Skin at the Cellular Level

Understanding why oral NMN works requires examining the signaling cascades it modulates. The Kim et al. study identified several key mechanisms, each addressing a distinct driver of photoaging.

MAPK pathway inhibition: UV-B radiation activates a signaling cascade involving three kinases: ERK, JNK, and p38. Together, these trigger inflammation and collagen breakdown. NMN supplementation suppressed the phosphorylation of all three, effectively dampening the inflammatory response that UV-B sets in motion.

MMP-1 suppression: Matrix metalloproteinase-1 (MMP-1) is the primary enzyme responsible for degrading type I collagen in the dermis. By inhibiting MMP-1, NMN directly preserves the structural scaffolding that keeps skin firm and resilient.

HAS-1 and HAS-2 restoration: This mechanism is rarely discussed in consumer content. NMN restored the expression of hyaluronan synthase genes (HAS-1 and HAS-2), the enzymes responsible for producing hyaluronic acid within the skin. This directly links oral NMN supplementation to improved skin hydration and plumpness from the inside out.

SOD restoration: NMN enhanced superoxide dismutase (SOD) activity in UV-B-exposed mice, indicating a systemic antioxidant defense that operates well beyond the skin's surface.

A complementary 2025 study published on PubMed added another layer: NMN blocks UV-B-induced collagen reduction by stimulating mitochondrial proline biosynthesis. Proline is the primary amino acid building block of collagen. By fueling its production at the mitochondrial level, NMN supports collagen synthesis through a pathway that topical products cannot reach.

There is also emerging research on synergistic protocols. A study on NMN combined with Lactobacillus fermentum TKSN041 demonstrated reduced photoaging damage via AMPK pathway activation, pointing toward next-generation longevity protocols that integrate gut health with skin protection.

Human Clinical Evidence: What RCT Data Tells Us About Dose and Duration

Animal models establish mechanisms. Human trials establish relevance. A 2022 randomized controlled trial using the Uthever NMN formulation enrolled 66 adults aged 40–65 and found that 300 mg/day of oral NMN for 60 days increased serum NAD+/NADH by 38% versus baseline, compared to only 14.3% in the placebo group. No serious adverse events were reported.

A 2024 systematic review and meta-analysis of 12 RCTs encompassing 513 participants confirmed that NMN supplementation produces a significant overall effect in raising blood NAD+ levels across studies. This is a pattern validated across multiple research groups and populations, not a single-study finding.

How does NMN compare to other NAD+ precursors? A human trial found that both NMN and NR sustainably double circulating NAD+ after two weeks, while nicotinamide (Nam) does not produce the same effect. This reinforces NMN's position as a superior precursor for those seeking measurable NAD+ restoration.

Beyond skin, a September 2025 open-label study in 15 women aged 40–50 found that 500 mg/day NMN for 12 weeks significantly increased hair growth density and diameter in 11 of 15 subjects, illustrating NMN's broader effects on epithelial tissue renewal. Published data suggests effective oral doses fall in the 300–500 mg/day range, with a minimum duration of 8–12 weeks for measurable outcomes.

What This Means for Your Longevity Skincare Protocol

NMN supplementation is not a reactive cosmetic fix. It is a preventive cellular strategy that addresses the upstream NAD+ depletion driving UV vulnerability before damage becomes visible. That distinction matters for anyone building a longevity-oriented skincare routine.

The inside-out protocol logic is straightforward: oral NMN works systemically to restore NAD+, activate sirtuins, suppress inflammatory signaling, and support hyaluronic acid synthesis. It complements topical skincare and SPF; it does not replace them. Think of it as fortifying the cellular infrastructure that your topical products depend on to work effectively.

For women between 40 and 55, the convergence of perimenopause, accelerating NAD+ decline, and cumulative photoaging creates a critical intervention window. This is especially true for lighter skin types (Fitzpatrick I–III), which carry a natural SPF of only 3.3 and are disproportionately vulnerable to UV-B-induced DNA damage and collagen degradation.

Not all NMN supplements are equivalent. Formulation quality, dosing precision, and third-party testing determine whether research findings translate into clinical outcomes. Dr. Katerina Noel, whose own cancer recovery journey led her to develop evidence-based longevity protocols, founded Dr. Noel on this principle. Every formulation is produced in Germany to pharmaceutical-grade standards and reviewed by a Medical & Scientific Advisory Board that includes dermatologists, geneticists, and longevity specialists.

Our approach combines ingestible NMN supplementation with topical formulations developed under medical advisory oversight, because the science confirms that true photoprotection requires both systemic and surface-level support.

The Science Is Clear — Your Cells Are Ready

The evidence builds a compelling case on three fronts. NAD+ depletion in skin is measurable and accelerates with age. Oral NMN demonstrably restores NAD+ and triggers protective molecular cascades, from MAPK inhibition to collagen preservation to hyaluronic acid synthesis. And the 2025 Kim et al. study is the first to validate this comprehensively against UV-B photoaging in a single model.

Photoprotection is no longer only a topical conversation. It begins at the mitochondrial level, in the very organelles that power your cells' ability to repair and renew.

The proactive, science-guided choices you make now compound over time, just as cellular damage does. This is the foundation of longevity medicine: intervene early, intervene precisely, and let biology do what it does best when properly supported. Explore Dr. Noel's longevity protocol and pharmaceutical-grade NMN formulations to begin building your inside-out photoprotection strategy.

Sources

• Kim et al., β-Nicotinamide Mononucleotide Enhances Skin Barrier Function and Attenuates UV-B-Induced Photoaging in Mice (Antioxidants, November 2025)
• NutritionFacts.org — Do NAD+ Levels Decline with Age?
• NMN Combined With Lactobacillus fermentum TKSN041 Reduces Photoaging Damage via AMPK Signaling (PMC, 2021)
• Goldman Laboratories — NAD+ Skin Benefits
• β-Nicotinamide Mononucleotide Blocks UVB-Induced Collagen Reduction via ROS/MAPK/AP-1 and Mitochondrial Proline Biosynthesis (PubMed, 2025)
• Multicentre RCT: Efficacy and Safety of Uthever NMN Supplement (Frontiers in Aging, 2022)
• Systematic Review & Meta-Analysis: Efficacy of Oral NMN Supplementation on Metabolism (2024)
• NMN.com — Human Trial Comparing Three NAD+ Precursors
• Renue By Science — Completed NMN Human Trials
• Comprehensive Review: Role of UV Radiation in Photoaging Across Skin Types (PMC, 2025)